236 related articles for article (PubMed ID: 18988126)
1. Conducting pharmaceutical R&D in India - Critical components of entry strategies.
Gulati R
IDrugs; 2008 Nov; 11(11):817-22. PubMed ID: 18988126
[TBL] [Abstract][Full Text] [Related]
2. Building local research and development capacity for the prevention and cure of neglected diseases: the case of India.
Kettler HE; Modi R
Bull World Health Organ; 2001; 79(8):742-7. PubMed ID: 11545331
[TBL] [Abstract][Full Text] [Related]
3. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective.
Federsel HJ
Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294
[TBL] [Abstract][Full Text] [Related]
4. The antibiotic pipeline--challenges, costs, and values.
Wenzel RP
N Engl J Med; 2004 Aug; 351(6):523-6. PubMed ID: 15295041
[No Abstract] [Full Text] [Related]
5. Does R&D pay?
Cavalla D; Minhas R
Drug Discov Today; 2010 Mar; 15(5-6):230-4. PubMed ID: 19931643
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical research and development.
McKercher PL
Clin Ther; 1992; 14(5):760-4; discussion 759. PubMed ID: 1468093
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
[TBL] [Abstract][Full Text] [Related]
8. Discontinued drugs in 2010: oncology drugs.
Williams R
Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
[TBL] [Abstract][Full Text] [Related]
9. Rebuilding the R&D engine in big pharma.
Garnier JP
Harv Bus Rev; 2008 May; 86(5):68-70, 72-6, 128. PubMed ID: 18543809
[TBL] [Abstract][Full Text] [Related]
10. Examining the link between price regulation and pharmaceutical R&D investment.
Vernon JA
Health Econ; 2005 Jan; 14(1):1-16. PubMed ID: 15386673
[TBL] [Abstract][Full Text] [Related]
11. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
12. India's growing clinical research sector: opportunity for global companies.
Varawalla N
IDrugs; 2007 Jun; 10(6):391-4. PubMed ID: 17642002
[TBL] [Abstract][Full Text] [Related]
13. Emerging trends in contract research industry in India.
Drabu S; Gupta A; Bhadauria A
Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
[TBL] [Abstract][Full Text] [Related]
14. Brazil: An emerging partner in drug R&D.
Rodrigues DG
IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
[TBL] [Abstract][Full Text] [Related]
15. How to revive breakthrough innovation in the pharmaceutical industry.
Munos BH; Chin WW
Sci Transl Med; 2011 Jun; 3(89):89cm16. PubMed ID: 21715677
[TBL] [Abstract][Full Text] [Related]
16. Process R&D under the magnifying glass: organization, business model, challenges, and scientific context.
Federsel HJ
Bioorg Med Chem; 2010 Aug; 18(16):5775-94. PubMed ID: 20621486
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical new product development: the increasing role of in-licensing.
Edwards NV
Anesthesiol Clin; 2008 Dec; 26(4):627-36, v. PubMed ID: 19041620
[TBL] [Abstract][Full Text] [Related]
18. [Yesterday, today and tomorrow: urology and the pharmaceutical industry: successful team work for the benefit of the patient].
Cardinal A
Urologe A; 2006 Sep; 45 Suppl 4():43-4. PubMed ID: 16955326
[No Abstract] [Full Text] [Related]
19. Brand-name drug companies fail to meet R&D commitments.
Kondro W
CMAJ; 2006 Aug; 175(4):344. PubMed ID: 16908891
[No Abstract] [Full Text] [Related]
20. Research and development productivity map: visualization of industry status.
Shimura H; Masuda S; Kimura H
J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
